The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its future within the broader market now raises questions about potential gains. Generic versions are undercutting market share, causing worries that betting on companies heavily reliant to Viagra's once-dominant position could be a problematic decision , es